DP
AMPE

Dearborn Partners’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Dearborn Partners’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-33
Closed -$35K – 299
2014
Q3 		$35K Hold
33
– – ﹤0.01% 296
2014
Q2 		$84K Hold
33
– – 0.01% 297
2014
Q1 		$64K Hold
33
– – 0.01% 290
2013
Q4 		$71K Buy
+33
New +$78K 0.01% 300

Other funds holding AMPE

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TC
Talkot Capital Sausalito, California $73.7M AUM 8.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NFG
Noven Financial Group Denver, Colorado $123M AUM 5.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dearborn Partners's AMPE Position: Q4 2014 in Review

Dearborn Partners sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2014, closing a stake of 33 shares — an estimated $35K sold.

Dearborn Partners first reported a position in AMPE in Q4 2013 and held it in 4 quarters. The position peaked at $84K in Q2 2014. 69 funds tracked by Wall St. Rank hold AMPE as of Q4 2014.

  • Dearborn Partners reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2014 after selling out during the quarter.
  • Dearborn Partners sold 33 Ampio Pharmaceuticals Inc. shares in Q4 2014, an estimated $35K.
  • Dearborn Partners first reported a position in Ampio Pharmaceuticals Inc. in Q4 2013 and held it in 4 quarters.
  • Dearborn Partners's Ampio Pharmaceuticals Inc. position peaked at $84K in Q2 2014.
  • 69 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2014.

Based on Dearborn Partners's 13F filing for Q4 2014, filed 28 Jan 2015.